Will Howat

Company: Abcam

Job title: Senior Director - Validation & Technical Quality

Bio:

Will Howat leads Abcam’s global Imaging and Immunohistochemistry team as Director of Antibody Validation and Characterisation. Prior to joining Abcam in 2018, he worked at AstraZeneca as Team Leader of its Molecular Pathology Group, where his team developed biomarker assays for preclinical, Phase 1 and Phase 2 clinical trials. Before that he was at the Cancer Research UK’s Cambridge Institute, where he set up and ran the Histopathology/ISH core facility for 9 years. He has also worked at the Wellcome Sanger Institute on the Atlas of Protein Expression and was responsible for R&D in within the Immunohistochemistry group.

Will has a BSc (Hons) in Immunology & Pharmacology from the University of Strathclyde and a PhD in Pathology from the University of Southampton. His publications span key journals such as The Lancet, Nature, Science, Nature Genetics, American Journal of Pathology, and the Journal of Pathology.

Seminars:

Set Yourself Up for Success: Achieve More with Better Antibodies 11:50 am

Passionate about solving the ‘reproducibility crisis ’abcam has performance data available for antibodies used in research and clinical development programs. Our aim is to remove uncertainty and guarantee reproducible results with our proprietary, recombinant rabbit monoclonal portfolio. In this presentation, abcam will present the industry-leading progress they have made to create highly validated and consistent…Read more

day: Day 2 Track A AM